Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response

Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response

Sandra Jernström,1,2 Vesa Hongisto,3 Suvi-Katri Leivonen,1,2 Eldri Undlien Due,1 Dagim Shiferaw Tadele,1 Henrik Edgren,4,5 Olli Kallioniemi,4 Merja Perälä,6 Gunhild Mari Mælandsmo,2,7,8 Kristine Kleivi Sahlberg,1,9 1Department of Cancer Genetics, Institute for Ca...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jernström S, Hongisto V, Leivonen SK, Due EU, Tadele DS, Edgren H, Kallioniemi O, Perälä M, Mælandsmo GM, Sahlberg KK
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
ERBB2
drug screening
gene expression
pharmacogenomics
predictors
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/5242fb84bf7e40c0a4884802397f2a64
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/5242fb84bf7e40c0a4884802397f2a64

Ejemplares similares